K. Stempinski

Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae in an urban public hospital pregnancy termination clinic

This study is a follow-up observational study to assess the prevalence of chlamydia (CT) and gonorrhea (GC) among women who undergo a first-trimester surgical termination in a large public, urban hospital-based termination clinic, and to compare the rates to previously published data. We conducted a retrospective chart review on 4197 patients who underwent CT and GC testing before an elective, first-trimester surgical termination between 1 June 2014 and 31 May 2015. The prevalence rates were calculated and compared by chi square tests to previously published data from 1 January 2006 to 30 June 2006 from the same publicly-funded pregnancy termination clinic. Our study population comprised mostly of African Americans (86.8%), and more than half were aged less than 25 years. The overall prevalence of CT in our population was 9.6%, which was significantly different to the prevalence of 11.4% in 2006 (p value = 0.03). The overall prevalence of GC in our population was 1.9%, which was not significantly different to the prevalence of 2.6% in 2006. To conclude, this study demonstrates the high prevalence rate of CT-positive and GC-positive patients in our publicly-funded pregnancy termination clinic. The prevalence of infection with CT and GC in our study is higher than in other family planning clinics. Regular screening of all patients who undergo induced termination in pregnancy termination clinics can provide a valuable opportunity for physicians to counsel patients about sexually transmitted infection prevention and treatment prior to the procedure or distribution of medications.

Utilization of the Family Planning Quotient in Three Cohorts of Women [250].

INTRODUCTION: In response to the Centers for Disease Control and Preventions reproductive life plan, we developed the Reproductive Life Index and its unit of measure, the Family Planning Quotient to visually present and quantitatively assess reproductive health goals and outcomes. The objective of this study is to present utilization of Family Planning Quotient in three populations. METHODS: The Family Planning Quotient is a ratio of the number of children a woman has divided by the number she wants at one time point. A Family Planning Quotient less than 1 indicates a woman wants more children and a Family Planning Quotient greater than 1 indicates a woman has achieved or exceeded her family plans. The Family Planning Quotient can be used on a population level to capture overall reproductive health status. The Family Planning Quotient was sampled in three populations: 468 family planning providers in a national survey of family planning providers, 1,780 patients presenting for first-trimester abortion, and 124 patients in the Title X program. RESULTS: Among family planning providers, 59.2% had a quotient less than 1, 39.3% equal to 1, and 1.5% greater than 1. Among first-trimester abortions, 35.9% had a quotient less than 1, 58.9% equal to 1, and 5.2% greater than 1. Among Title X programs, 44.4% had a quotient less than 1, 49.2% equal to 1, and 6.5% greater than 1. Family Planning Quotients were significantly different when stratified by age among the family planning providers (P<.001), patients presenting for first-trimester abortion (P<.001), and Title X programs (P=.004). CONCLUSION: The Reproductive Life Index/Family Planning Quotient is an innovative tool to assist patients and health care providers in the discussion of reproductive health plans and should be further implemented to demonstrate its effect on reproductive planning.

Get Yourself Tested 2011–2012: Findings and prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae at an urban public health system

During April 2011 and April 2012 the Get Yourself Tested campaign was launched throughout the Cook County Health and Hospitals System to promote testing of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) among 15–25-year-olds in a high-prevalence urban community. Retrospective data were collected and analysed. Demographic differences by CT and GC positivity were evaluated along with factors associated with CT and GC status. A total of 2853 tests were conducted among individuals aged 15–25 years. A total of 2060 (72%) females and 793 (28%) males were tested. Of those tested, 488 (17%) individuals tested positive for either CT or GC or both; 400 (14%) were positive for CT, 139 (5%) were positive for GC. The prevalence for GC was 8.8% (n = 70) in males compared to 3.3% (n = 69) in females (p < 0.001) and the prevalence of CT was 16% (n = 127) for males compared to 13.3% (n = 273) for females (p = 0.057). Women in a high-risk population are more likely to get tested for sexually transmitted infections; however, men are more likely to test positive for CT and GC. Get Yourself Tested is an important campaign to encourage wider spread testing among populations at risk in Cook County.